Eli Lilly and Company (NYSE: LLY) reported third quarter 2023 earnings results today. Worldwide revenue was $9.50 billion, up 37% compared to the same period a year ago. Net loss was $57.4 million, or $0.06 per share, compared to net income of $1.45 billion, or $1.61 per share, last year. Adjusted EPS fell 95% to […]
Eli Lilly and Company (NYSE: LLY) reported third quarter 2023 earnings results today. Worldwide revenue was $9.50 billion, up 37% compared to the same period a year ago. Net loss was $57.4 million, or $0.06 per share, compared to net income of $1.45 billion, or $1.61 per share, last year. Adjusted EPS fell 95% to […]
Eli Lilly and Company (NYSE: LLY) reported third quarter 2023 earnings results today.
Worldwide revenue was $9.50 billion, up 37% compared to the same period a year ago.
Net loss was $57.4 million, or $0.06 per share, compared to net income of $1.45 billion, or $1.61 per share, last year. Adjusted EPS fell 95% to $0.10.
For the full year of 2023, revenue is expected to be $33.4-33.9 billion.
